Genocea Biosciences, Inc. (NASDAQ:GNCA – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 3,590,000 shares, an increase of 118.9% from the May 15th total of 1,640,000 shares. Currently, 13.6% of the company’s stock are short sold. Based on an average daily volume of […]
Genocea Biosciences, Inc. (NASDAQ:GNCA – Get Rating) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 3,590,000 shares, a growth of 118.9% from the May 15th total of 1,640,000 shares. Currently, 13.6% of the company’s stock are sold short. Based on an average […]
Investment analysts at Oppenheimer started coverage on shares of Trevi Therapeutics (NASDAQ:TRVI – Get Rating) in a note issued to investors on Tuesday, The Fly reports. The brokerage set an “outperform” rating on the stock. A number of other equities research analysts have also commented on TRVI. Aegis began coverage on Trevi Therapeutics in a […]
Metacrine, Inc. (NASDAQ:MTCR – Get Rating) was the recipient of a large decrease in short interest in February. As of February 28th, there was short interest totalling 465,600 shares, a decrease of 20.9% from the February 13th total of 588,600 shares. Based on an average daily volume of 3,470,000 shares, the short-interest ratio is presently […]